A. Kashyap

发表

Solid cancers after bone marrow transplantation.

A. Nademanee, J. Niland, A. Krishnan, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.

A. Nademanee, J. Niland, A. Krishnan, 2000, Blood.

Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group.

A. Nademanee, J. Niland, G. Somlo, 1997, Blood.

Solid C ancers A fter B one M arrow T ransplantation

A. Nademanee, J. Niland, A. Krishnan, 2001 .

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

K. Sullivan, D. Furst, P. Emery, 2001, Annals of the rheumatic diseases.

High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission.

A. Nademanee, J. Niland, A. Krishnan, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.

J. Niland, K. van Besien, G. Somlo, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.

J. Wingard, B. Andersson, S. Forman, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Bone Marrow Transplantation for BCR-ABL Positive Acute Lymphoblastic Leukemia

J. Niland, M. Amylon, M. Slovak, 2001 .

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

L. Kappos, E. Havrdová, A. Steck, 2002, Journal of neurology.

Autologous bone marrow transplantation for non‐Hodgkin's lymphoma resulting in long‐term remission of coincidental Crohn's disease

S. Forman, A. Kashyap, 1998, British journal of haematology.

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.

J. Niland, J. Wingard, B. Andersson, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Polymyositis as a Manifestation of Chronic Graft‐Versus‐Host Disease

A. Nademanee, J. Niland, J. Ben-Ezra, 1996, Medicine.

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

L. Weiner, J. Antel, O. Stuve, 2000, Neurology.

Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.

J. Niland, A. Krishnan, R. Bhatia, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin

R. Vij, K. Trinkaus, P. Westervelt, 2001, Bone Marrow Transplantation.

Equivalence of 2 Effective Graft-Versus-Host Disease Prophylaxis Regimens : Results of a Pro s p e c t i ve

M. Amylon, R. Negrin, G. Long, 2000 .

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.

A. Nademanee, J. Niland, M. Amylon, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thalidomide as salvage therapy for chronic graft-versus-host disease.

J. Niland, R. Negrin, G. Somlo, 1995, Blood.

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

J. Wingard, B. Andersson, H. Fernandez, 2000, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for multiple sclerosis

L. Kappos, E. Havrdová, A. Steck, 2002, Journal of Neurology.

The effect of thymic function on immunocompetence following bone marrow transplantation.

K. Weinberg, S. Forman, G. Annett, 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

R Storb, S. Heimfeld, R. Storb, 2001, The New England journal of medicine.

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission

M. Amylon, M. Slovak, R. Negrin, 1999, Leukemia.

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.

A. Nademanee, J. Niland, A. Krishnan, 2000, Clinical lymphoma.

Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.

P. Brooks, P. Emery, J. Snowden, 2004, The Journal of rheumatology.

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring.

L. Weiner, S. Forman, H. Openshaw, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.

P. Thall, J. Wingard, B. Andersson, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.

J. Snowden, A. Kashyap, 2001, The Journal of rheumatology. Supplement.

Hematopoietic stem cell transplantation in multiple sclerosis

L. Kappos, E. Havrdová, J. Frederiksen, 2009, Acta neurologica Scandinavica.

Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (‐), CD14 (‐) and CD33 (‐)

J. Bennett, A. Kashyap, B. Seshi, 1992, British journal of haematology.